Understanding life and death at CD95

Advances in Experimental Medicine and Biology

Volumn 691, Issue , 2011, Pages 151-161

  Pforr, Carina ^a   Neumann, Leo ^a   Eils, Roland ^b   Krammer, Peter H ^a   Lavrik, Inna N ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR; FAS ANTIGEN; FAS LIGAND; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; PROCASPASE 8; TUMOR NECROSIS FACTOR RECEPTOR; CASPASE; CFLAR PROTEIN, HUMAN; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CELL DEATH; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SIGNAL TRANSDUCTION; ARTICLE; CHEMISTRY; METABOLISM;

ANTIGENS, CD95; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASES; CELL DEATH; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; HELA CELLS; HUMANS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 79954440928     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6612-4_16     Document Type: Conference Paper

References (34)

1. Arnold R, Liou J, Drexler HC, Weiss A, Kiefer F (2001) Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFkappaB into an inhibitor of NFkappaB. J Biol Chem 276:14675-14684
2. Ashkenazi A, Dixit VM (1998) Death receptors: Signaling and modulation. Science 281:1305-1308
3. Bagci EZ, Vodovotz Y, Billiar TR, Ermentrout GB, Bahar I (2006) Bistability in apoptosis: Roles of Bax, Bcl-2, and mitochondrial permeability transition pores. Biophy J 90:1546-1559
4. Barnhart BC, Legembre P, Pietras E, Bubici C, Franzoso G, Peter ME (2004) CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J 23:3175-3185
5. Bentele M, Lavrik I, Ulrich M, Stosser S, Heermann DW, Kalthoff H, Krammer PH, Eils R (2004) Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. J Cell Biol 166:839-851
6. Cheong R, Hoffmann A, Levchenko A (2008) Understanding NF-kappaB signaling via mathematical modeling. Mol Syst Biol 4:192
7. Eissing T, Conzelmann H, Gilles ED, Allgower F, Bullinger E, Scheurich P( 2004) Bistability analyses of a caspase activation model for receptor-induced apoptosis. J Biol Chem 279:36892-36897
8. Golks A, Brenner D, Fritsch C, Krammer PH, Lavrik IN (2005) c-FLIPR, a new regulator of death receptor-induced apoptosis. J Biol Chem 280:14507-14513
9. Golks A, Brenner D, Krammer PH, Lavrik IN (2006a) The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappa B activation. J Exper Med 203:1295-1305
10. Golks A, Brenner D, Schmitz I, Watzl C, Krueger A, Krammer PH, Lavrik IN (2006b) The role of CAP3 in CD95 signaling: New insights into the mechanism of procaspase-8 activation. Cell Death Differ 13:489-498
11. Hayden MS, Ghosh S (2004). Signaling to NF-kappaB. Genes Dev 18:2195-2224
12. Hoffmann A, Levchenko A, Scott ML, Baltimore D (2002) The I kappa B-NF-kappa B signaling module: Temporal control and selective gene activation. Science 298:1241-1245
13. Hoffmann JC, Pappa A, Krammer PH, Lavrik IN (2009) A new C-terminal cleavage product of procaspase-8, p30, defines an alternative pathway of procaspase-8 activation. Mol Cell Biol 29:4431-4440
14. Hua F, Cornejo MG, Cardone MH, Stokes CL, Lauffenburger DA (2005) Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: Molecular genetic tests of computational model predictions. J Immunol 175:985-995
15. Hughes MA, Harper N, Butterworth M, Cain K, Cohen GM, MacFarlane M (2009) Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. Mol Cell 35:265-279
16. Janes KA, Albeck JG, Gaudet S, Sorger PK, Lauffenburger DA, Yaffe MB (2005) A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 310:1646-1653
17. Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3:221-227
18. Kataoka T, Tschopp J (2004) N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway. Mol Cell Biol 24:2627-2636
19. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. Embo J 14:5579-5588
20. Krammer PH (2000) CD95's deadly mission in the immune system. Nature 407:789-795
21. Krammer PH, Arnold R, Lavrik IN (2007) Life and death in peripheral T cells. Nat Rev Immunol 7:532-542
22. Kreuz S, Siegmund D, Rumpf JJ, Samel D, Leverkus M, Janssen O, Hacker G, Dittrich- Breiholz O, KrachtM, Scheurich P,Wajant H (2004) NF kappa B activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. J Cell Biol 166:369-380
23. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S (2001) Cellular flice-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the cd95 death-inducing signaling complex. J Biol Chem 276:20633-20640
24. Lavrik IN, Golks A, Krammer PH (2005) Caspases: Pharmacological manipulation of cell death. J Clin Invest 115:2665-2672
25. Legewie S, Bluthgen N, Herzel H (2006) Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability. PLoS Comput Biol 2:e120
26. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817-827
27. Nelson DE, Ihekwaba AEC, Elliott M, Johnson JR, Gibney CA, Foreman BE, Nelson G, See V, Horton CA, Spiller DG, Edwards SW, McDowell HP, Unitt JF, Sullivan E, Grimley R, Benson N, Broomhead D, Kell DB,White MRH (2004) Oscillations in NF-kappa B signaling control the dynamics of gene expression. Science 306:704-708
28. PeterME, Budd RC, Desbarats J,Wiltrout S, Zornig M, Lynch DH (2007) The CD95 receptor: Apoptosis revisited. Cell 129:447-450
29. Rehm M, Huber HJ, Dussmann H, Prehn JHM (2006) Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. EMBO J 25: 4338-4349
30. Scaffidi C, Medema JP, Krammer PH, Peter ME (1997) FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem 272:26953-26958
31. Scaffidi C, Schmitz I, Krammer PH, Peter ME (1999) The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 274:1541-1548
32. Sprick M, Rieser E, Stahl H, Grosse-Wilde A, Weigand M, Walczak H (2002) Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. Embo J 21: 4520-4530
33. Su H, Bidere N,Zheng L, Cubre A, Sakai K, Dale J, Salmena L, Hakem R, Straus S, Lenardo M (2005) Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 307:1465-1468
34. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-305